Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Linagliptin on Diabetic Patients with COVID-19
IRCT20210812052156N1Phase 3Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of linagliptin in coronavirus disease 2019 (COVID-19) and type 2 diabetes mellitus (T2DM), sponsored by Gonabad University of Medical Sciences. Started Oct 2021; status: completed.
02
Drugs
linagliptin
03
Conditions
coronavirus disease 2019 (COVID-19)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20210812052156N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210812052156N1.